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AbstrACt
Introduction For women of the same age and body 
mass index, increased mammographic density is one of 
the strongest predictors of breast cancer risk. There are 
multiple methods of measuring mammographic density 
and other features in a mammogram that could potentially 
be used in a screening setting to identify and target 
women at high risk of developing breast cancer. However, 
it is unclear which measurement method provides the 
strongest predictor of breast cancer risk.
Methods and analysis The measurement challenge 
has been established as an international resource 
to offer a common set of anonymised mammogram 
images for measurement and analysis. To date, full 
field digital mammogram images and core data from 
1650 cases and 1929 controls from five countries 
have been collated. The measurement challenge is an 
ongoing collaboration and we are continuing to expand 
the resource to include additional image sets across 
different populations (from contributors) and to compare 
additional measurement methods (by challengers). The 
intended use of the measurement challenge resource 
is for refinement and validation of new and existing 
mammographic measurement methods. The measurement 
challenge resource provides a standardised dataset 
of mammographic images and core data that enables 
investigators to directly compare methods of measuring 
mammographic density or other mammographic features 
in case/control sets of both raw and processed images, for 
the purposes of the comparing their predictions of breast 
cancer risk.
Ethics and dissemination Challengers and contributors 
are required to enter a Research Collaboration Agreement 
with the University of Melbourne prior to participation 
in the measurement challenge. The Challenge database 
of collated data and images are stored in a secure data 
repository at the University of Melbourne. Ethics approval 
for the measurement challenge is held at University of 
Melbourne (HREC ID 0931343.3).
IntroduCtIon
Mammograms are the current standard 
in population- based screening for breast 
cancer in women aged 40 or above. For 
women of the same age and body mass index 
(BMI), increased mammographic density 
is one of the strongest predictors of breast 
cancer risk.1–3 There are multiple methods 
of measuring mammographic density and 
other features of a mammogram that could 
potentially be used in a screening setting 
strengths and limitations of this study
 ► The measurement challenge is a unique annotated 
resource that enables timely and prompt comparison 
of different mammographic measurement methods 
applied to full field digital mammogram images, and 
thereby robust assessment of which measurement 
method provides the ‘best’ predictor of breast can-
cer risk within different screening settings.
 ► The measurement challenge currently includes ano-
nymised mammographic images and core data from 
1650 cases and 1929 controls from five different 
sample populations.
 ► The measurement challenge is an ongoing collabo-
ration and we are continuing to expand the resource 
to include additional image sets across different 
populations (from contributors) and to apply addi-
tional measurement methods (by challengers).
 ► The measurement challenge provides a much- 
needed standardised dataset with which to refine 
and assess new or existing mammographic mea-
surement methods but is currently underpowered to 
examine the association between mammographic 
measures and breast cancer risk in non- European/
Caucasian populations.
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to identify and target women at high risk of developing 
breast cancer. However, it is unclear which measurement 
method provides the strongest predictor of breast cancer 
risk.
The measurement challenge is an international resource 
that offers a common set of raw and/or processed full field 
digital mammograms for measurement and analysis. By 
providing an annotated dataset of mammogram images 
and core data, this resource will enable investigators to 
directly compare methods of measuring mammographic 
density or other mammographic features as predictors of 
breast cancer risk.
Initiated in 2016, the measurement challenge has 
collated full field digital mammograms images and core 
data from 1650 cases and 1929 controls from five coun-
tries (Australia, Malaysia, Norway, UK and the USA) 
to date. Images have been randomly divided to form a 
training set and a validation set for challenge measure-
ment. Further contributions are welcomed.
There are currently eight challenger research groups 
who have applied measurement methods to the resource 
dataset. These include fully automated approaches (ie, 
AutoDensity, BIOMEDIQ, DeepRisk, Laboratory for 
Individualized Breast Radiodensity Assessment (LIBRA), 
MMTEXT, OpenBreast V.1.0 and VolparaDensity) and 
semiautomated methods (ie, Cumulus, including AltoCu-
mulus and CirroCumulus).
The measurement challenge is an ongoing collab-
oration and we are continuing to expand the resource 
to include additional image sets across different popu-
lations and to apply additional measurement methods. 
More image sets are needed to improve statistical power 
and provide sufficient data to address incompatibilities 
between measurement methods and image type and/or 
manufacturer.
The potential benefit of pooling and standardising 
mammographic images from different populations 
includes providing a large set of images with which 
to refine and assess new or existing mammographic 
measurement methods. We anticipate that the measure-
ment challenge will become a unique annotated 
resource for timely and prompt comparison of different 
mammographic measurement methods with the aim 
of identifying mammographic measures that the best 
predict breast cancer risk in different screening settings. 
Given the increased measurement and reporting of 
mammographic density internationally, identifying the 
measurement method/s that best discriminates women 
who will or will not be diagnosed with breast cancer in the 
future could substantially improve existing risk prediction 
models and ultimately help improve the efficiency and 
effectiveness of screening programs by triaging women 
according to risk. The cost and ease of implementing 
routine mammographic measurement in local clinical 
settings would depend on the requirements and idiosyn-
crasies of each screening programmes.
MEthods And AnAlysIs
As part of the first phase of the measurement challenge, 
full field digital mammogram images and core data 
from 1650 cases and 1929 controls have been collated. 
The resource has been collated from five contributing 
studies in Australia, Malaysia, Norway, the UK and the 
USA (henceforth contributors). Both contributors of 
case–control image sets and investigators interested in 
applying their measurement methods (henceforth chal-
lengers) are required to enter a Research Collaboration 
Agreement with The University of Melbourne prior to 
participation in the measurement challenge.
Data are obtained from existing epidemiological 
case–control studies or nested case–control studies. For 
the former, diagnostic or prediagnostic mammograms 
are obtained for cases with comparable mammograms 
obtained for controls. For nested case–control studies, 
mammograms taken at the time of entry into the cohort 
are used and incident cancers diagnosed within 1 year after 
the baseline screen negative mammogram are excluded 
to avoid masking bias or false negatives. Control selection 
differed slightly for each study (references provided in 
table 1); at a minimum, controls were frequency matched 
for age post hoc.
Table 1 describes the mammographic image data avail-
able by contributor, to date. Both raw and processed 
images are available for 1003 cases and 1283 controls; 
processed images are available for 1650 cases and 1929 
controls. Core participant data consist of year at mammo-
gram, year of birth, year of interview, BMI at mammo-
gram and ethnicity. For breast cancer cases, breast cancer 
laterality and year of diagnosis is also available. Additional 
image data include laterality, view and mammography 
machine manufacturer.
Anonymised mammographic images and core data 
are available to challengers interested in applying their 
measurement methods in two sets. Images from each 
source are randomly divided (50:50) in two (stratified by 
case–control status) and assigned to a ‘test set’ or a ‘vali-
dation set’. The test set is intended for use in refining new 
measurement methods or for training purposes, and the 
corresponding core data includes breast cancer status. It is 
made available to all challengers for a specified period of 
time. The validation set is provided for measurement vali-
dation and the corresponding core data does not include 
any information regarding breast cancer status. Both sets 
of images are securely transferred to challengers for the 
measurement using their method (multiple methods are 
permitted).
Thus far, eight challengers from Australia, Denmark, 
Finland, Malaysia, New Zealand, the UK and the 
USA have accessed the measurement challenge core 
data. Measurement methods include AutoDensity,4 
BIOMEDIQ,5 Cumulus (Sunnybrook Women’s Hospital, 
Toronto Canada), including AltoCumulus and Cirro-
Cumulus,6 DeepRisk, LIBRA,7 MMTEXT,8 OpenBreast 
V.1.09 and VolparaDensity.10 AutoDensity automatically 
preprocesses images by identifying the breast area using 
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thresholding algorithms (drawing on header informa-
tion where available, or otherwise through iterative opti-
misation), removing background objects such as image 
tags and image acquisition artefacts, and then reducing 
noise and improving image contrast. AutoDensity then 
segments the breast area into dense and non- dense tissue 
by identifying an optimal intensity threshold, output-
ting image files of the breast area and dense tissue data 
tables including the image/woman identifier, breast 
area, dense area and percent density. BIOMEDIQ is a 
deep- learning- based mammographic texture- based risk 
assessment. The deep- learning framework has a 5- layer 
convolutional neural network that maps mammographic 
patches to a cancer risk score. The Cumulus measures 
define mammographic density at successively higher 
pixel brightness thresholds. DeepRisk uses deep- learning- 
based methods to estimate breast cancer risk on mammo-
grams. Deep learning differs from other previous methods 
in that it automatically determines and extracts useful 
features using deep- learning- based methods without 
relying on manual extraction of features by experts. 
LIBRA is an adaptive multicluster fuzzy c- means segmen-
tation algorithm. For the MMTEXT algorithm, images 
are first downsized,11 leading to a new image for which 
each pixel had a much larger physical area than the orig-
inal. A gray- level co- occurance matrix (GLCM) is formed 
based on pixels within the breast area in each image, and 
a GLCM summary statistic (‘sum average’) is calculated 
for prediction. OpenBreast V.1.0 is an open software for 
breast cancer risk assessment based on fully automated 
parenchymal analysis of mammographic images. Paren-
chymal analysis is performed by applying computerised 
texture descriptors on each mammogram, followed by 
stepwise feature selection allowing first order interactions 
between features. The Volpara algorithm used an internal 
fat reference point within the mammogram to convert 
the intensities at each pixel to a thickness of fibroglan-
dular tissue.
All challengers are required to provide their measure-
ments from the validation set for statistical analysis at 
the University of Western Australia. Statistical criteria for 
assessing and comparing performance of each measure-
ment method are described in the Overview of analysis 
protocol below and will be completed by a statistician 
with no vested interest in the outcome.
overview of analysis protocol
To prepare the data for analysis, we exclude images 
of the affected breast for all cases. We also ensure that 
age distributions are similar across cases and controls. 
Age frequency matching is performed randomly within 
rolling 5- year intervals and separately by each image type 
and source.
For most women, four mammograms are available (ie, 
both sides and views). If multiple measurements have 
been submitted for the same person, we average these 
separately for each image type. The VolparaDensity chal-
lenger has provided a specific custom average which is 
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used. Details regarding its calculation can be provided on 
request.
Not all challengers can measure each image due to 
image type and/or quality; measured proportions will be 
reported by technique. A complete dataset that contains 
all images that every challenger can measure is used for 
the principal analysis. In addition, we also run all calcu-
lations individually for each challenger using all images 
that this specific challenger submitted.
Logistic regression is used to estimate the association 
between the mammographic measure and breast cancer 
risk for each method, stratifying by image type (raw or 
processed). Adjustment for covariates includes age, BMI, 
machine manufacturer and source.
Box- Cox transformations are used to better approxi-
mate normality,
 
f
(
x
)
=
xλ − 1
λ ifλ ̸= 0
log
(
x
)
ifλ = 0 
where  x is the mammographic measurement and λ 
is chosen to maximise the profile likelihood of a linear 
model of  x . The value of λ obtained and used for transfor-
mation will be reported for each measurement method.
We calculate standard ORs per unit increase in 
mammographic measure and as ORs per adjusted SD 
(OPERAs).1 To calculate OPERAs, the control popu-
lation mammographic measures are regressed on the 
adjustment covariates. The standardised residuals 
from this regression are an adjusted and independent 
mammographic measure that effectively controls for 
key population differences, strengthening our ability to 
compare ORs across measurement approaches. OPERAs 
are used to calculate any further metrics for assessment.
The following diagnostic statistics are considered for 
the assessment:
Akaike’s information criterion (AIC): AIC is a diag-
nostic statistic derived from information theory. It is calcu-
lated as minus twice the maximised log- likelihood plus 
twice the number of parameters. AIC is a relative statistic 
capturing information loss, here relative to a reference 
model without the mammographic measure. The smaller 
the AIC, the stronger the model.
Brier score: The Brier score can be used as a calibration 
measure reflecting a loss function. It is calculated as the 
mean of the squared residuals. Again, the model with the 
lowest Brier score is preferred.
Area under the receiver operating curve (AUC): AUC is 
a measure of discrimination between cases and controls. 
ROC curves visualise the trade- off between sensitivity and 
specificity visualised on a plane erected by sensitivity and 
1- specificity. A higher AUC means a better classification. 
They are calculated using the trapezoidal rule. We will 
also report a CI for the AUC bootstrapped 1000 iterations.
Partial AUC (pAUC): We will also report pAUC 
focusing on the section of the Receiver Operating Char-
acteristic (ROC) curve between 0.9 and 1 (high pAUC) 
and between 0 and 0.1 (low pAUC). CIs will be calculated 
and reported as for the aggregate AUC.
Adjusted for covariate AUC (AAUC): The AAUC 
can be adjusted for covariates. For analysing the 
mammographic measure–breast cancer association, age 
and BMI are critical confounders. Adjusting the AUC 
takes into account that covariates may affect the control 
distribution of the mammographic measure such that 
the underlying probability thresholds for discriminating 
between cases and controls are modelled to vary with 
age and BMI.
Net Reclassification Index (NRI): The (continuous) 
NRI reflects the proportion of cases correctly assigned a 
higher breast cancer risk and controls correctly assigned 
a lower breast cancer risk when moving from a null 
model to one including a mammographic measure as 
a predictor. It is calculated as the sum of NRIcases and 
NRIcontrols, where NRIcases is the proportion of cases 
that experience an increase in breast cancer risk minus 
the proportion with a decrease, and NRIcontrols is the 
proportion of controls with a decrease minus the propor-
tion with an increase in breast cancer risk.
Integrated discrimination improvement (IDI): The IDI 
is calculated similarly to the NRI, with IDIcases/IDIcon-
trols representing the difference between the mean of 
the predicted cancer risk from a model containing a 
mammographic measure as a predictor and the mean 
risk probability from the reference model without the 
mammographic measure for cases/controls, respectively. 
This means that the IDIcases capture the difference in 
the average sensitivity of the two models and similarly, 
the IDIcontrols represent the difference in the average 
1- specificity.
Comparisons: We will also test for equality of AUCs, 
using the AUCs. P values are reported for all possible indi-
vidual comparisons of the methods by mammogram type 
as well as a joint comparison of all methods by mammo-
gram type (testing for equality of all AUCs). Hence, small 
p values suggest that the challengers’ methods produce 
significantly different results.
Other considerations: Large sample sizes are needed to 
facilitate stratification by type of image (eg, processed vs 
raw; machine manufacturer) and ethnicity. The resource 
includes a mix of diagnostic and prediagnostic mammo-
grams and only the contralateral mammogram is used for 
breast cancer cases.
PAtIEnt And PublIC InvolvEMEnt
No patients are involved in this study. Patient data and 
images provided by contributors are supplied in an anony-
mised format, so that the data cannot be linked to personal 
information. Challengers agree to treat the Challenge Data-
base and its contents as Confidential Information of the 
University (or challenge contributor as the case may be); 
and not attempt to identify or identify the individuals whose 
information appears in the images and data.
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EthICs And dIssEMInAtIon
The measurement challenge is an ongoing collaboration 
and we are continuing to expand the resource to include 
additional image sets across different populations (from 
contributors) and to apply additional measurement 
methods (by challengers). Contributors are invited to 
submit large sets of case–control mammographic images 
(raw and processed full field digital mammograms) from a 
range of populations, plus corresponding core data timed 
to the mammogram. Each contributor is responsible 
for the ethics approval and participant consent for their 
respective sample populations; written informed consent 
is expected unless a waiver for informed consent is 
obtained. Challengers are invited to apply their measure-
ment methods to the validation set of case–controls 
images and provide their measurements for central anal-
ysis. All contributors and challengers are required to enter 
a Research Collaboration Agreement with the University 
of Melbourne prior to participation in the measurement 
challenge.
The Challenge database of collated data and images will 
be stored in a secure data repository at the University of 
Melbourne.
The measurement challenge is being organised by an 
international committee including: JLH (University of 
Melbourne), JeS (University of Western Australia), JoS 
(UCSF), IdSS (LSHTM), MN (University of Copenhagen), 
VM (IARC). To collaborate or request access to data and 
images from the measurement challenge, contact the 
corresponding author at  jennifer. stone@ uwa. edu. au.
AddItIonAl ConsIdErAtIons
The measurement challenge is a unique annotated 
resource that enables timely and prompt comparison of 
different mammographic measurement methods applied 
to full field digital mammogram images. However, full 
field digital mammograms differ by image type (processed 
vs unprocessed) and the processing differs by machine 
manufacturer, potentially introducing systematic bias to 
risk estimates. Therefore, more image sets are needed to 
improve statistical power and provide sufficient data to 
address incompatibilities between measurement methods 
and image type and/or manufacturer. Also, screening 
programmes differ by ethnicity of participants, equip-
ment used (eg, manufacturer) and screening protocols 
(eg, only a small proportion store unprocessed images). 
Therefore, we are comparing different mammographic 
measures within different screening settings to inform 
potential users about which measurement method 
provides the ‘best’ predictor of breast cancer risk. Identi-
fying women at increased risk due to high breast density 
could help target those who could benefit from supple-
mental screening using ultrasound, MRI or other modal-
ities. Clinical trials are currently underway to determine 
evidence- based screening recommendations for women 
with dense breasts.
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